Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 412.50
Bid: 410.50
Ask: 419.00
Change: 0.50 (0.12%)
Spread: 8.50 (2.071%)
Open: 415.50
High: 418.00
Low: 412.50
Prev. Close: 412.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Santander Mexico tender offer supplementary info

29 Oct 2021 07:00

RNS Number : 6989Q
Banco Santander S.A.
29 October 2021
 

 

Banco Santander, S.A. ("Banco Santander"), in compliance with the Spanish and Mexican market legislation and U.S. securities laws, hereby communicates the following:

OTHER MATERIAL INFORMATION

Banco Santander, S.A., as a supplement to its announcements of 26 March, 24 May and 8 June, 2021, announces that it expects to launch on 3 November, 2021, subject to obtaining the relevant regulatory approval and the terms and conditions that will be set forth in an informative memorandum (folleto informativo) (the "Informative Memorandum") and in a U.S offer to purchase (the "U.S. Offer to Purchase"), voluntary tender offers for cash (as provided under article 97 of the Mexican Securities Market Law (Ley del Mercado de Valores) and U.S. securities laws, as applicable) to acquire all of the Series B shares and American Depositary Shares (ADSs) of Banco Santander México, S.A., Institución de Banca Múltiple, Grupo Financiero Santander México ("Santander Mexico") not already held, directly or indirectly, by Banco Santander, which represent approximately 8.27% of Santander Mexico`s share capital (the "Tender Offers"). Banco Santander previously announced its intention to launch such Tender Offers for a price of 24 Mexican pesos for every share of Santander Mexico and 120 Mexican pesos for every ADS of Santander Mexico and now announces that it has determined to increase the price of the Tender Offers to 26.50 Mexican pesos for each Santander Mexico Series B share and the U.S. Dollar equivalent of 132.50 Mexican pesos per ADS.

 

Pursuant to the Informative Memorandum and the U.S. Offer to Purchase, respectively, the Tender Offers are expected to remain in force from 3 November, 2021 and until 7 December, 2021, unless the initial period is extended. Notwithstanding the foregoing, the offer period may be subsequently extended on one or more occasions at the discretion of Banco Santander in accordance to the terms of the Tender Offers.

 

For clarification purposes, the payment of a cash dividend amounting to 0.275 Mexican pesos per share (1.375 Mexican pesos per ADS) approved at Santander Mexico's ordinary general shareholders' meeting held on 25 October 2021 will not adjust the price of the Tender Offers.

 

The financial impacts of the Tender Offers by Santander Group are not materially different to the ones announced when the transaction was first informed.

 

 

Boadilla del Monte (Madrid), 29 October, 2021

 

IMPORTANT INFORMATION FOR INVESTORS ABOUT THE PROPOSED TRANSACTION

 

 

INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE TENDER OFFER STATEMENT, OFFER TO PURCHASE, SOLICITATION/RECOMMENDATION STATEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC AND THE CNBV REGARDING THE PROPOSED TRANSACTION CAREFULLY BEFORE MAKING A DECISION CONCERNING THE TENDER OFFER AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TENDER OFFER.

Such documents, and other documents filed by Banco Santander may be obtained without charge after they have been filed at the SEC's website at www.sec.gov and through the CNBV´s website at www.cnbv.gob.mx. The offer to purchase and related materials may also be obtained (when available) for free by contacting the information agent for the tender offer.

This communication shall not constitute a tender offer in any country or jurisdiction in which such offer would be considered unlawful or otherwise violate any applicable laws or regulations, or which would require Banco Santander or any of its affiliates to change or amend the terms or conditions of such offer in any manner, to make any additional filing with any governmental or regulatory authority or take any additional action in relation to such offer.

Numerous factors could affect our future results and could cause those results deviating from those anticipated in the forward-looking statements. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Our forward-looking statements speak only as at date of this communication and are informed by the knowledge, information and views available as at the date of this communication. Banco Santander is not required to update or revise any forward-looking statements, regardless of new information, future events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURPPGPGUUPGUAB
Date   Source Headline
7th Apr 202211:41 amRNSBuyback programme: transactions 31 March - 6 April
4th Apr 20225:39 pmRNSNew financial reporting
1st Apr 20225:57 pmRNSCapital reduction (2021 buy-back programme shares)
1st Apr 20224:30 pmRNS2022 AGM - Resolutions
1st Apr 20227:00 amRNSSantander confirms its financial targets for 2022
1st Apr 20227:00 amRNS2021 UK Annual Report
31st Mar 202211:33 amRNSBuyback programme: transactions 24 - 30 March
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:00 pmRNSForm 8.3 - Meggitt Plc
25th Mar 20222:29 pmRNSForm 8.3 - Meggitt plc
25th Mar 20222:27 pmRNSForm 8.3 - Clinigen Group plc
25th Mar 202212:51 pmRNSForm 8.3 - Ultra Electronics Holdings plc
24th Mar 202212:10 pmRNSBuyback programme: transactions 5 - 23 March
15th Mar 202212:40 pmRNSForm 8.3 - Meggitt plc
14th Mar 202211:51 amRNSCommencement of a program to repurchase own shares
9th Mar 202210:04 amRNSForm 8.3 - Meggitt Plc
3rd Mar 202211:58 amRNSForm 8.3 - Spectris plc
3rd Mar 202211:53 amRNSForm 8.3 - Oxford Instruments plc
1st Mar 20224:18 pmRNSOptional early redemption ISIN XS1602466424
28th Feb 202212:22 pmRNSDirector/PDMR Shareholding
28th Feb 20227:00 amRNSNotice of AGM
25th Feb 202211:33 amRNSForm 8.3 - Ultra Electronics Holdings plc
24th Feb 20225:35 pmRNSNotice of AGM
24th Feb 20222:49 pmRNSFurther re dividend declaration
24th Feb 20222:34 pmRNSDividend Declaration
18th Feb 202211:04 amRNSForm 8.3 - Meggitt plc
18th Feb 202210:55 amRNSForm 8.3 - Ultra Electronics Holdings plc
18th Feb 202210:47 amRNSForm 8.3 - Sanne Group plc
17th Feb 202210:54 amRNSForm 8.3 - Meggitt Plc
17th Feb 202210:49 amRNSForm 8.3 - Avast Plc
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
16th Feb 20223:20 pmRNSForm 8.3 - Meggitt Plc
16th Feb 20223:18 pmRNSForm 8.3 - Avast Plc
15th Feb 20229:07 amRNSForm 8.3 - Sanne Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.